SGLT2i as a Useful Adjunctive Medication for HNF4A-MODY

被引：4
|
作者：
Suzuki, Shigeru [1 ]
Kokumai, Takahide [1 ]
Furuya, Akiko [1 ]
Takahashi, Satoru [1 ]
机构：
[1] Asahikawa Med Univ, Dept Pediat, Asahikawa, Hokkaido, Japan
来源：
DIABETES CARE | 2023年 / 46卷 / 03期
基金：
日本学术振兴会;
关键词：
HYPERGLYCEMIA; HNF1A-MODY;
D O I：
10.2337/dc22-1573
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E74 / E75
页数：2
相关论文
共 50 条
  • [21] SGLT2i and postglomerular vasodilation reply
    van Bommel, Erik J. M.
    van Raalte, Daniel H.
    KIDNEY INTERNATIONAL, 2020, 97 (04) : 806 - 806
  • [22] Risk of infection lower with SGLT2i than DPP4i
    Reactions Weekly, 2024, 2017 (1) : 10 - 10
  • [23] Prolonged episodes of hypoglycaemia in HNF4A-MODY mutation carriers with IGT. Evidence of persistent hyperinsulinism into early adulthood
    Bacon, S.
    Kyithar, M. P.
    Condron, E. M.
    Vizzard, N.
    Burke, M.
    Byrne, M. M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : 384 - 385
  • [24] Response to SGLT2 Inhibitor May Be Altered in HNF1A-MODY
    Hohendorff, Jerzy
    Szopa, Magdalena
    Skupien, Jan
    Klupa, Tomasz
    Malecki, Maciej T.
    DIABETES, 2016, 65 : A308 - A309
  • [25] Prolonged episodes of hypoglycaemia in HNF4A-MODY mutation carriers with IGT. Evidence of persistent hyperinsulinism into early adulthood
    Bacon, S.
    Kyithar, M. P.
    Condron, E. M.
    Vizzard, N.
    Burke, M.
    Byrne, M. M.
    ACTA DIABETOLOGICA, 2016, 53 (06) : 965 - 972
  • [26] Clinical effects of SGLT2 inhibitors in seven persons with HNF1A-MODY (MODY3)
    Maagensen, Henrik
    Haedersdal, Sofie
    Krogh, Jesper
    Hansen, Torben
    Knop, Filip Krag
    Thuesen, Anne Cathrine Baun
    Vilsboll, Tina
    DIABETIC MEDICINE, 2024, 41 (10)
  • [27] Adjuvant Glucagon-Like Peptide 1 Receptor Agonist (GLP1 RA) Use in HNF1A-and HNF4A-MODY
    Broome, David
    Mehdi, Alina Z.
    Foss-Freitas, Maria C.
    Chase, Colby
    Gregg, Brigid
    Oral, Elif A.
    Herman, William H.
    DIABETES, 2024, 73
  • [28] Sacubitril/Valsartan and SGLT2i: a safe combination?
    Goena, C.
    Natividad, R.
    Rilo, I.
    Gomez, C.
    Perez De Nanclares, M.
    Lozano, A.
    Quintas, L.
    Zugazabeitia, G.
    Solla, I.
    Escolar, V.
    Rodriguez, I.
    Gil, P.
    Laskibar, A.
    Urreta, I.
    Romero, A.
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 : 141 - 141
  • [29] Evaluation of pregnancy outcomes and glycaemic control in hepatocyte nuclear factor 4 alpha - maturity onset diabetes of the young (HNF4A-MODY)
    Crowley, Mairead T.
    Lechuga, Begona Sanchez
    Burke, Marie
    Byrne, Maria M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2024, 193 : S127 - S127
  • [30] SGLT2I AS RENOPROTECTION TOOL IN CHILDREN WITH CKD
    Ivanov, Dmytro
    Ivanova, Mariia
    PEDIATRIC NEPHROLOGY, 2021, 36 (10) : 3325 - 3325
12345